Bank of Montreal’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,000
Closed -$60K 4559
2019
Q4
$60K Sell
11,000
-58,700
-84% -$330K ﹤0.01% 3761
2019
Q3
$399K Hold
69,700
﹤0.01% 2528
2019
Q2
$534K Buy
+69,700
New +$375K ﹤0.01% 2387
2019
Q1
Sell
-3,500
Closed -$23K 4637
2018
Q4
$23K Hold
3,500
﹤0.01% 3597
2018
Q3
$60K Sell
3,500
-77,600
-96% -$1.15M ﹤0.01% 3312
2018
Q2
$1.13M Buy
81,100
+2,500
+3% +$42.2K ﹤0.01% 1945
2018
Q1
$1.21M Buy
78,600
+26,700
+51% +$382K ﹤0.01% 1827
2017
Q4
$598K Buy
51,900
+51,400
+10,280% +$766K ﹤0.01% 2202
2017
Q3
$10K Buy
+500
New +$10.3K ﹤0.01% 3700

Other funds holding PGEN

Bank of Montreal's PGEN Position: Q2 2022 in Review

Bank of Montreal sold out of Precigen (PGEN) in Q2 2022, closing a stake of 212,610 shares — an estimated $449K sold.

Bank of Montreal first reported a position in PGEN in Q3 2013 and held it in 29 quarters. The position peaked at $2.05M in Q2 2014. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Bank of Montreal reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 212,610 Precigen shares in Q2 2022, an estimated $449K.
  • Bank of Montreal first reported a position in Precigen in Q3 2013 and held it in 29 quarters.
  • Bank of Montreal's Precigen position peaked at $2.05M in Q2 2014.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.